Security key
68235C206
Insight Molecular Diagnostics Inc. - Common Stock, no par value (IMDX)
CUSIP: 68235C206
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock, no par value
- Total 13F shares
- 15,248,594
- Total 13F value
- $46,050,393
- Share change
- +147,840
- SEC-reported price per share
- $3.02
- Number of holders
- 29
- Value change
- +$442,513
- Number of buys
- 15
- Number of sells
- 10
- Shares outstanding
- 32,330,312
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
29
Top holders
10
IMDX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Insight Molecular Diagnostics Inc. SEC filings
Insight Molecular Diagnostics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 68235C206
Recent filing periods:
Ownership snapshot
Top reported holders of IMDX - Insight Molecular Diagnostics Inc. - Common Stock, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Patrick W. Smith
Disclosed value leader
BROADWOOD CAPITAL INC
Comparable rows
15/15
Latest evidence
31 Mar 2025
3/4/5
13D/G
13F
Lead comparable stake: 10%
13D/G row: Patrick W. Smith
Showing 1-6 of 15 holder rows.
Quick read
Patrick W. Smith leads the comparable SEC ownership view at 10%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Patrick W. Smith's linked filing trail.
Comparable ownership
Top 5
Patrick W. Smith
10%
AWM Investment Company, Inc.
10%
BIO-RAD LABORATORIES, INC.
9.7%
BROADWOOD CAPITAL INC
35%
PURA VIDA INVESTMENTS, LLC
2.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Patrick W. Smith |
3/4/5
13D/G
10%+ Owner
|
10%
from 13D/G
|
$6,679,894
3,258,485 shares
|
— | 07 Feb 2025 |
| AWM Investment Company, Inc. |
13D/G
13F
Company
|
10%
|
$9,685,464
2,857,069 shares
|
+$5,257,076 | 31 Mar 2025 |
| BIO-RAD LABORATORIES, INC. |
13D/G
|
9.7%
|
$608,097
2,764,078 shares
|
$0 | 10 Feb 2025 |
| BROADWOOD CAPITAL INC |
13F
Company
|
35%
|
$34,914,906
11,410,100 shares
|
— | 31 Mar 2025 |
| PURA VIDA INVESTMENTS, LLC |
3/4/5
13F
10%+ Owner · Company
|
2.9%
from 13F
|
$3,044,309
16,591,052 shares
mixed-class rows
|
— | 14 Apr 2023 |
| VANGUARD GROUP INC |
13F
Company
|
0.82%
|
$812,298
265,457 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
29
Shares
15,248,594
Rows available
29
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
29
Q2 2025 holders
29
Holder diff
0
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend